Cargando…
Temporal Trends Of Pharmacologic Therapies For Patients With Chronic Obstructive Pulmonary Disease In Alberta, Canada
OBJECTIVES: To describe the trends in pharmacologic treatment for patients newly diagnosed with chronic obstructive pulmonary disease (COPD) in Alberta, Canada. METHODS: We linked Alberta health databases to identify patients aged ≥35 years with incident COPD between April 2010 and March 2017. Incid...
Autores principales: | Tran, Dat T, Akpinar, Ilke, Mayers, Irvin, Makhinova, Tatiana, Jacobs, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769052/ https://www.ncbi.nlm.nih.gov/pubmed/31576120 http://dx.doi.org/10.2147/COPD.S214191 |
Ejemplares similares
-
The Costs of Industry-Sponsored Drug Trials in Canada
por: Tran, Dat T., et al.
Publicado: (2019) -
The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
por: Akpinar, Ilke, et al.
Publicado: (2019) -
Authors’ Reply to Holko: “Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review”
por: Akpinar, Ilke, et al.
Publicado: (2017) -
Asthma-related emergency admissions and associated healthcare resource use in Alberta, Canada
por: Mayers, Irvin, et al.
Publicado: (2023) -
Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review
por: Akpinar, Ilke, et al.
Publicado: (2016)